Global crop nutrient giant Nutrien (TSX:NTR) is entering 2026 with growing optimism, forecasting continued strength in agricultural commodity fundamentals that should drive its fourth straight year of potash volume growth.
Speaking on the company’s fourth-quarter earnings call Thursday, Chief Financial Officer Mark Thompson outlined a bullish near-term outlook for key nutrients, with demand trends testing the limits of global supply chains.
“We’ve observed good engagement across all major markets, with most benchmark prices roughly 20 per cent higher than 12 months ago,” Thompson told analysts. “Trend line demand growth is testing existing global operating and supply chain capabilities, leading us to expect relatively tight fundamentals through 2026.”
The Saskatoon-based producer expects potash sales volumes between 14.1 million and 14.8 million tonnes this year. Nitrogen markets tell a similar story. Thompson noted persistent supply tightness coupled with rising consumption across Asian and Latin American markets. Nutrien projects 2026 nitrogen sales in the range of 9.2 million to 9.7 million tonnes.
The company delivered robust fourth-quarter results, with earnings surging to US$580 million from US$118 million in the prior-year period. Quarterly sales climbed to US$5.34 billion, representing approximately 4.7 per cent year-over-year growth.
On the strategic front, CEO Ken Seitz provided an update on the phosphate business review launched last November. Options under consideration include operational adjustments, partnership formation, or a potential divestiture.
“We’ve seen significant inbound interest,” Seitz said, adding that discussions will only commence once the company has fully prepared its data and clearly characterized the assets. The company expects to test market reception next quarter while simultaneously evaluating operational improvements at its phosphate facilities. Nutrien ranks as North America’s second-largest phosphate producer, with applications spanning fertilizers, animal feed, and industrial uses.
Shareholder returns remain a priority. The company declared a quarterly dividend of US$0.55 per share, marking a 1 per cent increase. The board also authorized a share repurchase program covering up to 5 per cent of outstanding common shares over the coming 12 months.
Nutrien’s stock staged a remarkable recovery in 2025, climbing 32 per cent after two consecutive years of declines. That momentum has carried into 2026.
Market observers attribute the rebound to improving demand expectations, disciplined cost management, and enhanced operational efficiency. With fundamentals stabilizing, Nutrien appears to be transitioning from a pure-play cyclical commodity name toward a more balanced investment proposition combining reliable dividend income with measured growth potential.
